CIBC Asset Management Inc - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 253 filers reported holding SAGE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
CIBC Asset Management Inc ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$229,000
-23.4%
1,6330.0%0.00%
-50.0%
Q2 2019$299,000
+15.0%
1,6330.0%0.00%0.0%
Q1 2019$260,000
+12.6%
1,6330.0%0.00%
+100.0%
Q3 2018$231,000
-9.8%
1,6330.0%0.00%
-50.0%
Q2 2018$256,000
+23.1%
1,633
+26.4%
0.00%
+100.0%
Q1 2018$208,000
-2.3%
1,2920.0%0.00%0.0%
Q4 2017$213,0001,2920.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Casdin Capital, LLC 312,000$29,886,0005.11%
DAFNA Capital Management LLC 104,306$9,991,0004.97%
Palo Alto Investors LP 850,977$81,515,0004.34%
BB BIOTECH AG 1,375,229$131,733,0004.22%
Eventide Asset Management 936,000$89,659,0003.97%
TRV GP II, LLC 37,362$3,579,0003.56%
KINGDON CAPITAL MANAGEMENT, L.L.C. 146,179$14,002,0002.11%
SUFFOLK CAPITAL MANAGEMENT LLC 111,908$10,720,0002.06%
OAK RIDGE INVESTMENTS LLC 231,483$22,174,0001.60%
Rhenman & Partners Asset Management AB 137,339$13,156,0001.50%
View complete list of SAGE THERAPEUTICS INC shareholders